Other News To Note
Thursday, December 23, 2010
Marshall Edwards Inc., of San Diego, will acquire isoflavone-based intellectual property from Novogen Ltd., of Sydney, Australia, for $4 million in convertible preferred stock.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.